These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 15020654

  • 1. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D, Delgado M.
    Arch Immunol Ther Exp (Warsz); 2001 Jun; 49(2):101-10. PubMed ID: 11348014
    [Abstract] [Full Text] [Related]

  • 3. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M, Sun W, Leceta J, Ganea D.
    J Immunol; 1999 Oct 15; 163(8):4213-23. PubMed ID: 10510358
    [Abstract] [Full Text] [Related]

  • 4. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.
    Delgado M, Gonzalez-Rey E, Ganea D.
    FASEB J; 2004 Sep 15; 18(12):1453-5. PubMed ID: 15231725
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M, Leceta J, Gomariz RP, Ganea D.
    J Immunol; 1999 Oct 01; 163(7):3629-35. PubMed ID: 10490956
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D, Rodriguez R, Delgado M.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar 01; 49(2):127-42. PubMed ID: 12887096
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 9. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 15; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 15; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
    Delgado M, Gonzalez-Rey E, Ganea D.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():233-8. PubMed ID: 16888172
    [Abstract] [Full Text] [Related]

  • 12. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 15; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 15; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 14. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression.
    Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D.
    Ann N Y Acad Sci; 2000 Jun 15; 921():68-78. PubMed ID: 11193881
    [Abstract] [Full Text] [Related]

  • 15. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
    Chorny A, Gonzalez-Rey E, Delgado M.
    Ann N Y Acad Sci; 2006 Nov 15; 1088():187-94. PubMed ID: 17192565
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 17. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK.
    Mukohyama H, Ransjö M, Taniguchi H, Ohyama T, Lerner UH.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):158-63. PubMed ID: 10777696
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells.
    Delgado M, Leceta J, Ganea D.
    FASEB J; 2002 Nov 29; 16(13):1844-6. PubMed ID: 12223451
    [Abstract] [Full Text] [Related]

  • 19. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E, Delgado M.
    Curr Opin Investig Drugs; 2005 Nov 29; 6(11):1116-23. PubMed ID: 16312132
    [Abstract] [Full Text] [Related]

  • 20. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile.
    Neves BM, Cruz MT, Francisco V, Garcia-Rodriguez C, Silvestre R, Cordeiro-da-Silva A, Dinis AM, Batista MT, Duarte CB, Lopes MC.
    Mol Immunol; 2009 Aug 29; 46(13):2481-92. PubMed ID: 19520433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.